On August 13th, LIVZON PHARMA (01513) spent 4.0393 million yuan to repurchase 101,500 shares of A-shares.
Lizhu Pharmaceuticals (01513) announced on August 13, 2025, that the company will invest 403.93 million RMB...
LIVZON PHARMA (01513) announced on August 13, 2025, that the company will invest 4.0393 million yuan to repurchase 101,500 A-shares, with a repurchase price of 39.33-40.27 yuan per share.
Related Articles
Lenovo Group's quarterly revenue is close to 100 billion yuan, with the AI PC accelerating penetration and maintaining the number one position globally.
LENOVO GROUP (00992) first quarter performance of fiscal year 25/26 exceeded expectations, with revenue hitting a new historical high for the same period.
"China+N" model drives Lenovo (00992) to achieve record high performance in Q1, with double-digit growth in revenue and profit from the Chinese market.
Lenovo Group's quarterly revenue is close to 100 billion yuan, with the AI PC accelerating penetration and maintaining the number one position globally.
LENOVO GROUP (00992) first quarter performance of fiscal year 25/26 exceeded expectations, with revenue hitting a new historical high for the same period.
"China+N" model drives Lenovo (00992) to achieve record high performance in Q1, with double-digit growth in revenue and profit from the Chinese market.
RECOMMEND
Hong Kong Stock Concepts | Boosting Consumption: Dual Interest Subsidy Programs Implemented to Benefit Key Sectors
13/08/2025
Countdown to Evergrande’s Delisting: HK$350 Billion in Liabilities, Only HK$2 Billion Recovered
13/08/2025
U.S. July Tariff Receipts Reach Record High, Yet Budget Deficit Continues to Grow
13/08/2025
